Newly-released Biopsy Guidance System Market analysis report by Future Market Insights shows that global sales of the Biopsy Guidance System Market in 2021 were held at US$ 1.1 Billion. With a CAGR of 5.8% from 2022 to 2032, the market is projected to reach a valuation of US$ 2 Billion by 2032. The market for Stereotactic Guided Biopsy is expected to be the highest revenue-generating segment expected to grow at a CAGR of 6.1% from 2022 to 2032.
| Attribute | Details |
|---|---|
| Global Biopsy Guidance System Market (2022) | US$ 458 Million |
| Global Biopsy Guidance System Market (2032) | US$ 2 Billion |
| Global Biopsy Guidance System Market CAGR (2022 to 2032) | 5.8% |
| USA Biopsy Guidance System Market (2022) | US$ 444 Million |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Biopsy Guidance System Market research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Biopsy Guidance System Market increased at around 5.1% CAGR.
The rising prevalence of cancer, the rise in the geriatric population, the rising demand for non-invasive procedures, technological innovations, and government initiatives, are the key drivers for the market. A biopsy is one of the most common procedures for diagnosing cancer and other chronic diseases, and it is used to diagnose breast, brain, skin, and prostate cancers.
The rising incidence of cancer is one of the major drivers of market expansion. Because the biopsy guidance system is one of the most important requirements for the initial diagnosis of cancer, the market is expected to grow at a rapid pace over the forecast period.
As a result of the substantial increase in the incidence of cancer, more advanced technology, safer, and more effective biopsies are being developed, which is driving the biopsy market. Non-invasive procedures are becoming more popular, which is fueling market growth in that area.
Patients owing to the high costs and painful side effects that come with this treatment, resulting in undiagnosed or inadequate diseases later in life, often avoid invasive biopsies. These symptoms consequently increase mortality rates and lead to greater expenses and difficulties in treatment.
The demand for non-invasive procedures is skyrocketing owing to the boost in demand for biopsy guidance systems, resulting in a surge in the need for biopsy guidance systems. Patients recover faster and are less traumatized as a result of these procedures. Owing to these factors, Biopsy Guidance System Market is projected to grow at a CAGR of 5.8 % over the coming 10 years.
When the tumor is located deep within the body, image-guided biopsies are used. Biopsy guidance systems are both cost-effective and simple to operate. They can provide superb real-time details that cause the procedure to be less uncomfortable and more efficient for the patient. Furthermore, these guided biopsies can enable to rapid inspect numerous lesions in the axillary and sub-areolar areas.
The segment is growing due to the rising demand for robotic biopsies due to their less invasive nature. A rising number of product launches, combined with quick FDA approval, are also contributing to the segment's growth.
Increased awareness of biopsy guidance systems, increased healthcare infrastructure development, impressive reimbursement policies, increased investment in healthcare research and development, and an upsurge in the number of hospitals and diagnostic centers are expected to drive demand for biopsy guidance systems during the forecast period.
Principal Consultant
North America accounts for the largest market share during the forecast period. Because of factors such as improved infrastructure, rising patient awareness, and the presence of key players in the region also the presence of a large number of academic institutes, enhanced healthcare infrastructure, and Research and Development institutes are all contributing to the market's growth. In addition, the USA has a large number of market participants.
On the other hand, the market in the Asia Pacific is expected to grow at the fastest pace with an absolute dollar opportunity of US$ 880 Million during the forecast period. The presence of leading manufacturers in countries such as Japan, as well as a growing number of local producers in countries like China and India, are driving the regional market forward.
Over the projected period, the market is expected to be fuelled by an increasing number of healthcare institutions, the rising need for diagnostic centers, and expanding Research and Development projects. The market is expected to grow over the forecast period, owing to an increase in the number of cancer cases and advancements in biopsy guidance systems.
USA Biopsy Guidance System Market Analysis
The USA is expected to account for the largest market of US$ 771.4 Million by the end of 2032. This is attributable to a significant increase in research & development activities. Furthermore, advances in the healthcare industry have resulted in the development of new technologies and equipment, which is further expected to boost the market in the USA. Furthermore, the presence of well-known corporations, as well as early access to new and developing technologies, is projected to aid the market in the USA in maintaining its global market supremacy in the next years.
China Biopsy Guidance Market Analysis
The market in China is expected to grow at a CAGR of 7.1% during the forecast period, approaching a market revenue of US$ 230.9 Million by 2032. In Asian countries, traditional biopsy techniques such as core-needle biopsies and surgical biopsies continue to dominate the cancer diagnostic market. A significant increase in cancer incidence is a major driver of regional market expansion.
UK Biopsy Guidance Market Analysis
The market in the UK is projected to reach a valuation of US$ 89 Million by 2032, growing at a CAGR of 6.5% from 2022 to 2032. During this period, the market is projected to garner an absolute dollar opportunity of US$ 41 Million.
Japan Biopsy Guidance Market Analysis
In Japan, the market is expected to reach US$ 78 Million by 2032. Growing at a CAGR of 7.1% from 2022 to 2032, the market in the country is expected to gross an absolute dollar opportunity of around US$ 39 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
During the forecast period, the stereotactically guided biopsy segment is anticipated to experience rapid expansion. New product launches, originating with new and improved product efficacy, and the introduction of technological advances using 2D-3D image guidance, will help propel the segment forward.
The combination of increased awareness and the introduction of innovative medical technologies has led to an increased demand for stereotactic-guided biopsies. In addition, the introduction of automated core biopsy guns has boosted the popularity of this method. Several medical facilities have broadened the use of stereotactic-guided biopsy to all challenging mammographic lesions.
Over the forecast period, the ultrasound-guided biopsy segment is expected to increase at the fastest rate. It is the safest and most effective imaging technique for targeting fine-needle aspirations and percutaneous biopsies. Using real-time imaging, it is a secure and controllable method for targeting needles for abdominal and pelvic tissues and masses.
It has several advantages in comparison to CT-guided biopsies, such as portability, cost, and the lack of ionizing radiation. In a safe fashion, the procedure can be carried out on a variety of lesions that are as small as 1 cm. Therefore, an ultrasound-guided biopsy is becoming increasingly popular among patients.
With many local firms vying against multinational competitors, the market is significantly fragmented. To stay competitive in the industry, major businesses are focusing more on research and development of new products.
The prominent players in the Biopsy Guidance System Market are Becton, Dickinson, and Company, Hologic, Inc., Devicor Medical Products, Inc., B. Braun Melsungen AG, and ARGON MEDICAL. Major market players use a variety of methods to preserve their dominance, including high Research and Development activity, global expansion strategies, broad product offers, and frequent introduction of advanced versions of existing items.
Some of the recent developments of key Biopsy Guidance System providers are as follows:
Similarly, the team at Future Market Insights, which is available in the full report, has tracked recent developments related to companies offering Biopsy Guidance Systems.
The global Biopsy Guidance System Market is worth more than US$ 1.1 Billion at present.
The value of the Biopsy Guidance System Market is projected to increase at a CAGR of around 5.8% from 2022 to 2032.
The value of Biopsy Guidance System Market increased at a CAGR of around 5.1% from 2017 to 2021.
The rising prevalence of cancer, the rise in the geriatric population, the growing demand for non-invasive procedures, and technological innovations are all driving the growth of the biopsy guidance system market.
The market for Biopsy Guidance System Market in China is projected to expand at a CAGR of around 7.1% from 2022 to 2032.
While the market in South Korea is expected to grow at nearly 6.7%, the market in Japan is projected to register a CAGR of nearly 7.1% from 2022 to 2032.
1. Executive Summary | Biopsy Guidance System Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2017 to 2021 and Forecast, 2022 to 2032
6.1. Historical Market Analysis, 2017 to 2021
6.2. Current and Future Market Projections, 2022 to 2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2017 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2017 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Product Type, 2017 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032
8.3.1. Stereotactic Guided Biopsy
8.3.2. Ultrasound Guided Biopsy
8.3.3. MRI Guided Biopsy
8.4. Market Attractiveness Analysis By Product Type
9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032
9.3.1. Brain Biopsy
9.3.2. Breast Biopsy
9.3.3. Other Applications
9.4. Market Attractiveness Analysis By Application
10. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End-User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By End-User, 2017 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-User, 2022 to 2032
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Diagnostic Centers
10.3.4. Research and Academic Institutes
10.4. Market Attractiveness Analysis By End-User
11. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Region, 2017 to 2021
11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
12.4.1. By Country
12.4.1.1.United States of America
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product Type
12.4.3. By End-User
12.4.4. By Application
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By End-User
12.5.4. By Application
13. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product Type
13.4.3. By End-User
13.4.4. By Application
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By End-User
13.5.4. By Application
14. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. United Kingdom
14.4.1.4. Italy
14.4.1.5. Spain
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Product Type
14.4.3. By End-User
14.4.4. By Application
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By End-User
14.5.4. By Application
15. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Product Type
15.4.3. By End-User
15.4.4. By Application
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By End-User
15.5.4. By Application
16. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By End-User
16.4.4. By Application
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By End-User
16.5.4. By Application
17. Key Countries Market Analysis 2017 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.2.2.1. By Product Type
17.2.2.2. By End-User
17.2.2.3. By Application
17.3. Canada Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.3.2.1. By Product Type
17.3.2.2. By End-User
17.3.2.3. By Application
17.4. Mexico Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.4.2.1. By Product Type
17.4.2.2. By End-User
17.4.2.3. By Application
17.5. Brazil Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.5.2.1. By Product Type
17.5.2.2. By End-User
17.5.2.3. By Application
17.6. Germany Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.6.2.1. By Product Type
17.6.2.2. By End-User
17.6.2.3. By Application
17.7. France Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.7.2.1. By Product Type
17.7.2.2. By End-User
17.7.2.3. By Application
17.8. Italy Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.8.2.1. By Product Type
17.8.2.2. By End-User
17.8.2.3. By Application
17.9. Spain Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.9.2.1. By Product Type
17.9.2.2. By End-User
17.9.2.3. By Application
17.10. UK Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.10.2.1. By Product Type
17.10.2.2. By End-User
17.10.2.3. By Application
17.11. Nordic Countries Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.11.2.1. By Product Type
17.11.2.2. By End-User
17.11.2.3. By Application
17.12. China Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.12.2.1. By Product Type
17.12.2.2. By End-User
17.12.2.3. By Application
17.13. Japan Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.13.2.1. By Product Type
17.13.2.2. By End-User
17.13.2.3. By Application
17.14. South Korea Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.14.2.1. By Product Type
17.14.2.2. By End-User
17.14.2.3. By Application
17.15. GCC Countries Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.15.2.1. By Product Type
17.15.2.2. By End-User
17.15.2.3. By Application
17.16. South Africa Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.16.2.1. By Product Type
17.16.2.2. By End-User
17.16.2.3. By Application
17.17. Turkey Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2017 to 2032
17.17.2.1. By Product Type
17.17.2.2. By End-User
17.17.2.3. By Application
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. Becton
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Dickinson and Company
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Hologic Inc
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Devicor Medical Products, Inc.
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. B. Braun Melsungen AG
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. ARGON MEDICAL
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports
Biopsy Guidance System Market
